Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Cancer Res. 2015 Nov 20;76(3):664–674. doi: 10.1158/0008-5472.CAN-15-0828

Figure 3. Protein expression of activated MRs in DLBCL patients.

Figure 3

Protein expression by immunohistochemistry analysis in TMAs from FL and DLBCL patients. (A) Expression of MRs in FL and DLBCL patients defined by GCB markers. (B) Expression of MRs in FL and DLBCL patients with t(14;28) translocation. Bars represent number of patients with positive MR expression. See Table 2 for details.